Nectar Lifesciences settles ₹1,338.35 crore secured debt

Nectar Lifesciences Limited has confirmed the full repayment and settlement of its secured debt, including accrued interest, owed to a consortium of lenders referred to as "Banks." The company officially filed and registered the satisfaction of this charge on October 22, 2025, with the Registrar of Companies, Punjab and Chandigarh, Ministry of Corporate Affairs, Government of India.

The consortium charge covered all assets of the company, both immovable and movable, including current assets. The total amount settled was ₹1,338.35 crore. This satisfaction was granted in favor of SBICAP Trustee Company Limited, which acted as the Security Trustee for the Banks, in accordance with the provisions of Chapter VI of the Companies Act, 2013.

This disclosure was made under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has requested that this significant financial event be taken on record by the National Stock Exchange of India Limited and BSE Limited.